top of page

Our leadership team has a proven track record across drug discovery, development and commercialization

Sue_Dillon Fall 2020 Vedanta Head Shot_e
Susan Dillon, PhD

Co-founder, President and Chief Executive Officer

Aro Biotherapeutics Karyn O’Neil, PhD.jp
Karyn O’Neil, PhD

Co-founder and Chief Scientific Officer

Aro Biotherapeutics Sukumar Sakamuri.jpg
Sukumar Sakamuri, PhD

Chief Technology Officer

Aro Biotherapeutics Adam Dinerman_.jpg
Adam Dinerman, PhD

Vice President of Chemistry, Manufacturing and Controls (CMC)

ARO leadership Steve Nadler copy.jpg
Steven Nadler, PhD

Senior Vice President of Discovery and Translational Research

Aro Biotherapeutics Mark Laurenzi.jpg
Mark Laurenzi

​Chief Administrative Officer & Vice President, Legal

bottom of page